ANTARES PHARMA INC (ATRS)

US0366421065 - Common Stock

5.59  0 (0%)

After market: 5.59 0 (0%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
2018
(2018-12-31)
2017
(2017-12-31)
Revenue
183.98M149.60M123.90M63.60M54.50M
Cost Of Goods
68.28M63.10M50.50M31.10M27.50M
Gross Profit
115.70M86.50M73.40M32.50M27.00M
Operating Expenses
88.36M72.90M72.40M49.10M43.50M
Research and Development
14.50M10.10M10.60M12.30M13.10M
Selling, General, and Administrative Expenses
72.82M62.50M61.40M36.20M29.80M
Operating Income
27.34M13.60M1.00M-16.60M-16.50M
Interest Income/Expense
-3.61M-3.80M-3.50M-2.70M-1.40M
Other Income/Expense
-50.00K100.00K500.00K300.00K300.00K
Income Before Taxes
62.27M9.90M-2.00M-6.50M-16.70M
Income Tax
15.98M-46.30M0.000.000.00
Net Income
46.29M56.20M-2.00M-6.50M-16.70M
EBITDA
31.24M16.23M3.56M-13.88M-14.40M
 
Per Share Data
EPS Diluted Total Ops
0.260.33-0.01-0.04-0.11
Non GAAP EPS
0.270.060.00-0.04-0.10
 
Statistics
Gross Profit Margin
62.89%57.82%59.24%51.10%49.54%
Profit Margin
25.16%37.57%-1.61%-10.22%-30.64%
Operating Profit Margin
14.86%9.09%0.81%-26.10%-30.28%

All data in USD

Charts